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Abstract
Background: Placental malfunction in preeclampsia is believed to be a consequence of aberrant differentiation of
trophoblast lineages and changes in utero-placental oxygenation. The transcription factor Snail, a master regulator
molecule of epithelial-mesenchymal transition in embryonic development and in cancer, is shown to be involved
in trophoblast differentiation as well. Moreover, Snail can be controlled by oxidative stress and hypoxia. Therefore,
we examined the expression of Snail and its downstream target, e-cadherin, in human normal term, preterm and
preeclamptic placentas, and in pregnant rats that developed preeclampsia-like symptoms in the response to a 20-
fold increase in sodium intake.
Methods: Western blotting analysis was used for comparative expression of Snail and e- cadherin in total protein
extracts. Placental cells expressing Snail and e-cadherin were identified by immunohistochemical double-labeling
technique.
Results: The levels of Snail protein were decreased in human preeclamptic placentas by 30% (p < 0.01) compared
to normal term, and in the rat model by 40% (p < 0.001) compared to control placentas. In preterm placentas, the
levels of Snail expression varied, yet there was a strong trend toward statistical significance between preterm and
preeclamptic placentas. In humans, e-cadherin protein level was 30% higher in preeclamptic (p < 0.05) placentas
and similarly, but not significantly (p = 0.1), high in the preterm placentas compared to normal term. In the rat
model of preeclampsia, e-cadherin was increased by 60% (p < 0.01). Immunohistochemical examination of human
placentas demonstrated Snail-positive staining in the nuclei of the villous trophoblasts and mesenchymal cells and
in the invasive trophoblasts of the decidua. In the rat placenta, the majority of Snail positive cells were
spongiotrophoblasts of the junctional zone, while in the labyrinth, Snail-positive sinusoidal giant trophoblasts cells
were found in some focal areas located close to the junctional zone.
Conclusion: We demonstrated that human preeclampsia and the salt-induced rat model of preeclampsia are
associated with the reduced levels of Snail protein in placenta. Down-regulation of the transcription factor Snail in
placental progenitor cell lineages, either by intrinsic defects and/or by extrinsic and maternal factors, may affect
normal placenta development and function and thus contribute to the pathology of preeclampsia.
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Preeclampsia, a devastating, life-threatening, human
pregnancy complication, develops in 3-10% of pregnan-
cies. Clinical symptoms include a sudden onset of
hypertension accompanied by proteinuria, edema and
often fetal growth restriction [1]. The placenta of
patients with preeclampsia is malformed [2]. It has been
hypothesized that abnormalities in trophoblast function
may contribute to placental defects associated with pree-
clampsia [3]. An increased proliferation of progenitor
villous cytotrophoblastic cells (VCT) and an augmented
apoptosis of the terminally differentiated syncytiotropho-
blast (SynTB) results in thinning and distortion of the
syncytial layer, and in the appearance of multinucleated
syncytial buds [2,4,5]. The villous injury in preeclampsia
is associated with poor perfusion/oxygenation of the
intervillous space, utero-placental hypoxia, and oxidative
stress [6,7]. Proper oxygenation of the placenta is
achieved through remodeling of the maternal spiral
arteries by a population of VCTs which, upon contact
with the decidua, acquire an invasive phenotype and are
hence called extravillous trophoblast (EVT). In pree-
clampsia, EVT invasion is limited and vascular transfor-
mation is incomplete [2]. Transformation of polarized,
non-motile, proliferative epithelia-like VCT into highly
invasive EVT requires loss of polarity, down-regulation
of epithelia-specific adhesion molecules, up-regulation of
extracellular matrix receptors, and de novo expression
of matrix degradation proteins[ 8 ] .T h i st r a n s f o r m a t i o n
to some extent resembles the process of epithelial-
mesenchymal transition (EMT), which is common in
embryonic development and in metastastic cancers [9].
EMT is commonly initiated by down-regulation of the
adhesive junction protein, e-cadherin. Similarly, in nor-
mal placenta, invasive and migratory, individual and
aggregated EVTs exhibit reduced, discontinuous expres-
sion of e-cadherin [10]. Conversely, in preeclampsia,
EVTs fail to down-regulate e-cadherin during the initia-
tion of invasion in anchoring cell columns, and also dur-
ing the fusion of the giant multinucleated cells in the
inner myometrium [11-13].
In embryogenesis and cancer, e-cadherin expression is
under the control of the Wnt pathways and/or the zinc
finger transcription factor Snail [9,14]. At the transcrip-
tional level, Snail is regulated by many signaling path-
ways including those that are crucial for placental
development, such as RAF/MEK/ERK and PI3K/AKT/
mTOR [15]. Post-transcriptional regulation of the highly
unstable Snail protein is under control of GSK-3b,a
member of WNT signaling cascades, and hypoxia-indu-
cible factor alpha (HIF-1a) [16,17]. Moreover, Snail
expression is also sensitive to hypoxia, either directly
through activation of the HIF-1a responsive element on
its promoter, or by such mediators of hypoxic signals as
EGF, TGFa,bsa n dT N F a [14]. Snail up-regulation by
HIF-1a in cultured human first trimester villous
explants reduces e-cadherin expression and activates an
invasion program [18]. Also, Snail has been shown to
down regulate e-cadherin during syncytialization of
BeWo trophoblast cell line [19]. In cultured rodent tro-
phoblast cells, Snail expression correlates with the tran-
sition from proliferating to terminally differentiated
stages [20,21]. It also has been shown that the number
of Snail positive EVTs in the basal plate of the human
placenta is increased in preeclampsia and HELLP syn-
drome compared to normal [22], which does not concur
with a commonly accepted notion of limited invasive
capacity of the EVT in preeclampsia.
Disturbed placenta is believed to be a primary cause of
excessive maternal inflammatory response, which in turn
instigates endothelial dysfunction and the increased vas-
cular reactivity in preeclampsia [1]. Defects in endothe-
lial function contribute to derangements of sodium-
volume homeostasis and thus compromise cardiovascu-
lar adaptations to pregnancy. A variety of animal models
which, to a different degree, mirror the vascular pathol-
ogy seen in human preeclampsia, have been developed
[23]. Several studies demonstrated that high sodium
uptake during the last week of the rat pregnancy can
induce such manifestations of preeclampsia as elevated
blood pressure, decreased activity of the renin-angioten-
sin-aldosterone system, renal dysfunction and fetal
growth restriction [24-26]. During the last week of nor-
mal rat pregnancy, the trophoblast cells invade the
mesometrial triangle, thus stimulating vascular remodel-
ing of maternal arteries through replacement of the
maternal endothelium [27]. During the same period,
maternal blood pressure gradually falls in spite of blood
volume expansion and activation of the renin-angioten-
sin-aldosterone system [26].
The aim of this study was to examine the protein
levels of transcription factor Snail and e-cadherin in pla-
cental samples from women with preeclampsia, and
from normotensive gestationally-matched preterm and
term controls at delivery. We also examined Snail/e-cad-
herin expression in near-term placentas from rats devel-
oping preeclampsia-like symptoms in response to high
sodium intake.
Methods
Collection of placental tissues
The human placenta samples were collected at The
Toledo Hospital and St. Vincent Mercy Medical Center
in Toledo, Ohio, according to approval of the University
of Toledo Biomedical Research Review Board, and after
informed patient consent. Placental tissues were col-
lected from 9 patients after normal term delivery, from
8 patients with preeclampsia and from 5 patients with
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clamptic according to recommendations given by the
American Society of Hypertension [28]. All studied pre-
eclamptic placentas were from women who developed
severe hypertension (systolic blood pressure ≥ 160, dia-
stolic ≥ 110), and heavy proteinuria (≥ 4 g of protein in
a 24 hour urine collection, or ≥ 3 +p r o t e i no nd i p s t i c k
measurement on two or more occasions). All 5 preterm
deliveries were associated with premature rupture of
amniotic membranes. All patients who had normal or
premature deliveries did not have any prior diagnosed
pregnancy complications. Immediately after delivery, the
peripheral parts of placenta, without any visible infarcts
or retroplacental clots, were snap frozen in liquid nitro-
gen or preserved in 10% formalin.
The salt-induced model of rat preeclampsia was
described in detail in several publications [24-26]. Ethical
protocol for the rat studies was approved by the Animal
Care and Use Committee of the Intramural Research
Program, National Institute on Aging [24,29]. Briefly, in
the experimental group of Sprague-Dawley pregnant rats,
regular drinking water was replaced with water contain-
i n g1 . 8 %N a C l .T h es a l to v e r d o s er e g i m ew a ss t a r t e da t
13dpc because the last week of normal rat pregnancy is
accompanied by blood volume expansion, activation of
the renin-angiotensin-aldosterone system and a signifi-
cant fall in arterial blood pressure. The rat placentas used
in the study were extracted from exactly the same control
and experimental animal groups (5 and 9 rats respec-
tively) that were thoroughly described earlier [24,29].
After extraction, the whole placentas were snap frozen
and sent to our laboratory on dry ice.
Protein extraction
Large, randomly chosen pieces of human placental tis-
sues (up to 20 g) taken from two areas containing both
fetal and uterine surfaces, and entire rat placentas were
homogenized in liquid nitrogen. The resulting powder
was transferred into ice-cold RadioImmunoPrecipitation
Assay (RIPA) buffer, containing 50 mM Tris-HCl, pH
7.5, 150 mM NaCl, 1% Nonidet P-40, 5% sodium deoxy-
cholate, 0.1% SDS, and protease inhibitors (Protease
Inhibitor Cocktail, Sigma) a n dp r o c e s s e da sp r e v i o u s l y
described [30].
Western blotting and immunohistochemistry
Western blotting analysis was carried out using standard
protocol as previously described [30]. Briefly, from 10 to
20 μg of protein (equal amounts for each gel) were
loaded into each well. Proteins were transferred by
semi-dry method and then processed exactly as thor-
oughly described earlier [30]. ImageJ software based
analysis (http://rsbweb.nih.gov/ij) was performed to
quantify the bands obtained via Western blot analysis.
T h ea r e au n d e rt h ec u r v e( A U C )o ft h es p e c i f i cs i g n a l
was corrected for the AUC of the actin loading control.
T h ea v e r a g ev a l u ef o rt h es a m p l e sf r o mn o r m a lt e r m
(human) or control (rat) placentas was set as 1 and
other conditions were recalculated correspondingly to
allow ratio comparisons.
For double immunohistochemistry of the human pla-
centas, deparaffinized and re-hydrated 5 μm thick placen-
tal sections were washed in TBS, blocked in TBS
containing 10% goat serum and 5% BSA for 2 hours at
room temperature, and probed with anti-Snail antibodies
(ab17732, or ab85935, Abcam, Cambridge, MA, USA)
diluted 1:200 in 5% goat serum/2.5% BSA in TBS for 1
hour at room temperature and overnight at 4°C. After
washing, the slides were boiled in acetic buffer (Vector
Laboratories, Burlingame, CA, USA) in a conventional
microwave. Then, the slides were probed with anti-e-cad-
herin antibodies (BD Bioscience, Sparks, MD, USA)
diluted 1:150 in 1.5% goat serum in TBS. The endogen-
ous peroxidase activity was blocked with 3% H2O2 in
methanol. E-cadherin antibodies were detected first using
anti-mouse HRP-conjugated polymer (Zymed, San-Fran-
cisco, CA, USA) for 30 min followed by the color devel-
opment with DAB. To detect the anti-Snail antibody, we
used anti-rabbit ABC-AP kit and Fast Red chromophore
according to standard procedure (Vector Laboratories).
Since whole placentas from experimental rats were
utilized for protein extraction, we used commercially
available slides of definitive rat placenta for immunohis-
tochemical detection of Snail protein (ab4623, Abcam).
The slides were boiled in acetic buffer, and then sections
were blocked with 1.5% goat serum in TBS for 1 hour at
room temperature. The tissue sections were first probed
with anti-Snail antibody diluted 1:50 in 1.5% goat serum
for 1 hour at room temperature. Afterward, the staining
protocol was the same as described for human placenta.
Anti-Snail antibodies (ab17732, or ab85935, Abcam)
were raised against the same peptide sequence. We
tested their specificities by applying the anti-Snail anti-
bodies with this peptide (ab19126, Abcam).
Statistical analysis
Data are presented as the mean ± standard error of the
mean unless otherwise specified. One-way ANOVA fol-
lowed by Tukey HSD test was used to compare three
groups of human samples. Unpaired Student’s t-test was
used to evaluate the difference between rat groups. Sta-
tistical significance was reported at the *p < 0.05,* * p<
0.01 and ***p < 0.001 levels.
Results
The three groups studied were not significantly different
from one another with respect to maternal age at time
of delivery (Table 1). Average gestational age was also
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clampsia groups of patients. Thus, the placenta samples
from preterm deliveries served as gestation-matched
controls for analysis of Snail/e-cadherin proteins in pre-
eclampsia. The preeclampsia group was heterogeneous
with regard to gestational age and fetal birth weight at
delivery, yet all samples from preeclamptic placentas
were obtained in the preterm period.
Western blotting examination of proteins extracted
from human placentas showed that the level of Snail
protein was decreased on average by 30% in preeclamp-
sia compared to normal term (Figure 1). Immunohisto-
chemical analysis demonstrated intensive staining of the
Snail protein in the villi of normal term placenta where
it was localized in the nuclei of two different cell popu-
lations, the mesenchymal cells and VCTs. In the
decidua, Snail positive nuclei were found in EVTs which
were negative for e-cadherin staining (Figure 2). In line
with Western blotting data, the preeclamptic placentas
show fewer Snail-positive cells. Western blotting
revealed variable expression of Snail among the preterm
placentas. No statistically significant differences were
found between preterm and term placentas or between
preterm and preeclamptic placentas after analysis of
Snail expression by Western blotting. However, there
was a strong trend toward statistical significance
between preterm and preeclamptic placentas (Figure 1).
The expression of e-cadherin was lower (by 30%) in
term placentas than in preterm and preeclamptic pla-
centas as was demonstrated by Western blotting (Figure
1). However, a statistically significant difference in e-
cadherin expression was found between term and pree-
clamptic samples only. Reduction in e-cadherin protein
level in the term placentas compared to preterm ones is
in agreement with widely appreciated phenomenon that
the relative number of proliferative VCTs is decreased
close to the term [2]. Immunohistochemical analysis
demonstrated strong staining for e-cadherin in VCTs in
both preterm and preeclamptic placentas (Figure 2). E-
cadherin connects neighboring VCT-VCT and VCT-
SynTB interfaces, and is expressed by proliferative
VCTs. E-cadherin is down-regulated during the fusion
of more differentiated VCTs to SynTB [31].
Pregnant rats receiving high dose of NaCl during the
last week of gestation develop symptoms of preeclamp-
sia such as high blood pressure, proteinuria, fetal growth
restriction, and enhanced vascular reactivity [24-26,29].
Unrelated to human preeclampsia, additional, pathophy-
siological changes in pregnant rats used in the study
included significantly less weight gain (~7% vs ~36%)
and fewer (2-3) pups than in normal pregnancy[24,29].
Western blotting analysis demonstrated that in the pla-
centas of rats with salt-induced preeclampsia, Snail pro-
tein expression is decreased by 40% and e-cadherin level
increased by 60% compared to control pregnant rats
(Figure 3). Immunohistochemical staining of the rat
definitive placenta with anti-Snail antibodies revealed
strong nuclear and weak cytoplasmic presence of Snail
in spongiotrophoblasts in the junctional zone, and in
the sinusoidal trophoblast giant cells (TGC) on the per-
iphery of the labyrinth (Figure 4). Immunohistochemical
analysis confirmed that in the rat term placenta e-cad-
herin is present in the SynTB covering the maternal
sinusoides of the labyrinth (Figure 4) [32].
Discussion
In this study, we have demonstrated that human placen-
tas from patients with preeclampsia contain significantly
reduced level of the transcription factor Snail compared
with normal term placentas. We also showed that in the
human placenta, Snail protein is expressed in the VCTs
and mesenchymal cells of the villi, and in the EVTs of
the decidua. Our data only partially agree with the pre-
vious analysis of Snail protein distribution in the human
placenta by Blechschmidt et al. [22]. These authors
found strong Snail immunoreactivity in the ETVs of the
basal plate and weak Snail immunoreactivity in the
VCTs using antibodies which are not recommended
specifically for immunohistochemistry (Sn9H2, ab31787,
Abcam). (We tested this antibody on the human pla-
centa sections and found very weak and irregular immu-
noreactivity in the deciduas.) Based on calculations of
the immunostaining intensity score for e-cadherin and
Snail-positive EVTs in the basal plate, Blechschmidt et
al. [22] reported an increase in Snail immunoreactivity
levels accompanied by a reduction of e-cadherin
Table 1 Clinical characteristics of patients in the study
Normal term deliveries Preterm deliveries Preeclampsia
Patients 95 8
Maternal age (years) 29.7 ± 6.4 (22-34) 32.6 ± 7.2 (29-38) 25.8 ± 6.6 (20-36)
Gestational age at
deliveries (weeks)
38.3± 0.5 (38-39) 35.4 ± 1.1 (34-36)*** 31.3 ± 3.1 (28-36)***
Birth weight (percentile) 77.3 ± 8.2 (70-90) 65.0 ± 26.9 (25-90) 39.5 ± 34.9 (5-95)*
Values represent group mean ± SD. Numbers in the parenthesis show the range of the values
*p < 0.05 preeclampsia versus both preterm and term deliveries
***p < 0.001 preterm and preeclampsia deliveries versus normal term
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normal term placentas. Yet, our observation does not
contradict Blechschmidt et al. for at least two reasons.
First, we estimated Snail/e-cadherin levels in total
homogenates of large pieces of placenta, where the
majority of proteins belongs to villous tissue; and sec-
ond, there is only limited invasion of EVTs in decidual
segments of the placental edges [33]. Thus, any changes
in Snail/e-cadherin expression in the EVT of the basal
plate in our samples of placenta wouldn’t significantly
alter total levels of these proteins. Our data for e-cad-
herin expression in the villous compartment of normal
and preeclamptic placentas are in agreement with sev-
eral reports [11,34,35].
Proper spatio-temporal induction, activation and
degradation of Snail may be essential for the control of
the VCT maturation and thus the maintenance of con-
tinuous, uninterrupted syncytium. In addition to e-
cadherin repression, Snail regulates cell cycle progres-
sion and confers resistance to cell death as has been
previously shown for fetal hepatocytes, epithelial cells,
and mouse embryos [36-38]. In preeclampsia, the syncy-
tial layer of the villi in some areas is discontinuous,
while in others parts it forms the thick aponecrotic
knots and sprouts [4]. Mesenchymal cells of the villi, in
contrast to the trophoectoderm-derived epithelial-like
VCTs, originate from extraembyonic mesoderm, which
is formed during primary EMT at the early stages of
human development. Thus, villous mesenchymal cells
may retain Snail expression from this period onward.
The exact role(s) of Snail in the stroma remains to be
elucidated and might be related to the regulation of
fibroblast/myofibroblast differentiation and angiogenesis.
Remarkably, morphologically preeclamptic placentas are
distinctive due to the altered branching pattern of the
villous tree, particularly when preeclampsia is combined
Figure 1 Western blotting analysis of Snail and e-cadherin expression in the total protein extracts from human placentas.A
representative immunoblot is shown (Snail) from at least four separate runs of each sample (A), and graph (C) demonstrating densitometry
analysis of Snail protein levels in normal term, preeclamptic, and preterm placentas (n = 36, 32, 30 respectively). For Snail, the ANOVA test
revealed a significant difference among the three groups (p value = 0.0100). However, the Tukey HSD post-hoc test only indicated a statistically
significant difference when comparing the normal term group and the preeclampsia group (p value = 0.0085). The difference between the
preterm and the preeclamptic samples was not significant (p = 0.0941). Representative immunoblot (e-cadherin) from three separate gels (B), and
graph showing densitometry analysis of e-cadherin levels in the three groups studied (D) (n = 27, 24 and 15 for normal term, preeclamptic, and
preterm placentas respectively). For e-cadherin, the ANOVA test also revealed a significant difference among the three groups (p value = 0.0265).
Again, the Tukey HSD post-hoc test only indicated a statistically significant difference when comparing the normal term group and the
preeclampsia group (p value = 0.0397). The difference between the preterm and normal term group was not statistically significant (p = 0.1). * p
< 0.05; ** p < 0.01
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internal and external factors may contribute to the
development of human preeclampsia by aberration of
essential stages of placental development.
In the rat definitive placenta, Snail is highly expressed
in spongiotrophoblasts, the TGC precursor cells in the
junctional zone (Figure 4). We also found focal expres-
sion of Snail in the sinusoidal TGC at the periphery of
the labyrinth. Rodent and human placentas are similar
in basic morphology and functions. However, there are
some differences in the structure and formation of the
chorion [39]. Rodent labyrinth, which is functionally
analogous to primate chorionic villi, is lined from the
maternal side with one layer of mononuclear sinusoidal
TGC and two layers of SynTB. The SynTB contacting
fetal mesenchyme originates from chorionic ectoderm
enriched with e-cadherin positive progenitor cells. The
outer SynTB and sinusoidal TGC are derived from the
inner part of the ectoplacental cone where the majority
of trophoblast progenitor cells, committed to SynTB
fate, persistently express e-cadherin. Before 8dpc of rat
placental development, e-cadherin is localized to tropho-
blasts; at 9dpc its expression is confined exclusively in
trophoblast derived cells at the extraembyonic ectoderm,
and from 10dpc onward, e-cadherin remains exclusively
expressed in the labyrinth [32]. Thus, in the outer layers
of the ectoplacental cone, e-cadherin is lost from 7dpc
onward when most of the Snail-positive cells appear. In
situ hybridization analysis demonstrated that from
7.5dpc Snail transcripts were detected in the ectoplacen-
tal cone in precursor cells of TGC and, at much lower
levels, in the proliferative trophoblasts of the chorion
Figure 2 Immunohistochemical analysis of Snail and e-cadherin proteins expression in human normal term, preeclamptic and preterm
placentas. E-cadherin (stained brown) is present in the basement membranes of the villi and, to a lesser extent, in the cytoplasm of VCT where
it forms a connection between neighboring VCTs, and between VCT and overlying SynTB (arrowheads). Snail (stained red) is localized mostly in
the nuclei of VCT and mesenchymal cells (short arrows). A normal placenta (A) and a preeclamptic placenta (B) are shown. In preeclampsia, there
is a significant reduction in Snail expression. The premature placenta (C) shows a similar staining pattern to the term placenta. The maternal-fetal
interface of a preterm placenta (D) reveals expression of Snail in EVT (long arrows), which lack e-cadherin on their membranes. Note that EVTs
which express e-cadherin are Snail negative. The loss of e-cadherin by EVT is believed necessary for proper invasion and implantation
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Page 6 of 11Figure 3 Western blotting analysis of Snail and e-cadherin expression in the total protein extracts from rat placentas. Representative
immunoblot from 3 independent runs for each sample (Snail) (A), and graph demonstrating densitometry analysis of Snail protein levels in the
placentas of control pregnant rats and rats loaded with NaCl (n ≥ 15) (C). Representative immunoblot from 2 independent runs for each sample
(e-cadherin) (B), and graph showing densitometry analysis of e-cadherin levels in the two groups studied (n ≥ 10) (D).**p < 0.01, *** p < 0.001
Figure 4 Immunohistochemistry of Snail and e-cadherin expression in normal definitive rat placenta. The photomicrographs show that
Snail (stained red) is present in the nuclei of spongiotrophoblast cells of the junctional zone. E-cadherin (stained brown) is localized to the
SynTB of the labyrinth (A). Snail positivity is also found in mononuclear sinusoidal TGC in some sinusoids positioned close to the junctional zone
(arrow) (B)
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the spongiotrophoblast layer and in some focal areas of
the labyrinth [41]. Therefore, only a small number of
Snail-positive cells are present in the developing labyr-
inth before 13dpc. The junctional zone encloses a highly
proliferative cell population until day 14 of gestation,
afterward the mitotic activity at this zone ceases sharply
[42]. Thus, an up-regulation of Snail in the junctional
zone spongiotrophoblasts may inhibit their proliferation
[36]. Notably, down-regulation of Snail expression takes
place at the border between the population of spongio-
trophoblasts and endocycling TGC [20]. In Rho-1 tro-
phoblast cell line, down-regulation of Snail promotes
entry into endoreduplication through control of the “G2
decision point” [20]. The trophoblasts are the only type
of mammalian cells that posses the ability to quit mito-
sis and enter into endocycle, thus multiplying DNA con-
tent in the range 8 N-64 N in the human and up to
4096 N in rodents [42-44]. These polyploid cells form
an invasive front when they contact maternal decidua
and play a crucial role in placental development and its
communication with maternal tissues [42-44].
In rodents, in contrast to humans, e-cadherin and
Snail are persistently expressed in the majority of cells
positioned in two different compartments throughout
placental development. The only exception is a small
number of mononuclear TGC in the sinusoids located
close to the junctional zone (Figure 4). Interestingly,
SynTB progenitor cells in rodent placenta (like VCT in
human) have never been verified [39].
We have also found that Snail is down-regulated and
e-cadherin is up-regulated in rat placentas, when preg-
nant rats developed preeclampsia-like symptoms in
response to NaCl overload. How can the expression of
these proteins be coupled if they are expressed by dis-
tinct populations of cells? We speculate that decreased
levels of Snail in the spongiotrophoblasts of salt-loaded
pregnant rats could boost the endoreduplication process,
thus amplifying the number of TGC. The TGCs pro-
duce activin, a TGFb family member protein, which can
trigger differentiation of progenitor trophoblast cells
away from spongiotrophoblast/TGC fate toward SynTB
as suggested in Natalie et al. [45]. Therefore, in the rat,
Snail functions appear to be restricted to the control of
spongiotrophoblast differentiation.
Snail expression, stability and activity are under con-
trol of integrated and complex cellular signaling net-
works which can be furthermore affected by
perturbations in the oxygen level [14,46]. Oxidative
stress triggers Snail transcription directly through eleva-
tion of ROS or by activation of NF-B signaling pathway
[14,47]. From the other side, hypoxia promotes Snail
protein stability by inhibiting Snail proteasome degrada-
tion. HIF-1a has been shown to down regulate F-box
E3 ubiquitin ligase FBXL14, which targets specifically
the cytoplasmic portion of Snail in some cancerous cell
lines [17]. Additionally, two highly HIF-up regulated
proteins, lysyl oxidase (LOX) and LOX-like 2 (LOXL2)
can stabilize Snail and therefore may alter its activity,
however, this interaction seems to be cell-line specific
[48,49]. Interestingly, while hypoxia strongly elevates
LOX gene expression, its enzymatic activity requires
subsequent re-oxygenation [50]. LOX and LOXL2,
which are generally known as classical proteins respon-
sible for the cross linking of collagen and elastin, are
normally expressed in the human placenta, and in the
VCT and SynTB particularly, throughout gestation [51].
Since preeclamptic placentas are characterized by
increased oxidative stress [52], over-expression of active
HIF-1a and 2-a [53] and reduced activity of proteaso-
mal proteins [54], an up-regulation of Snail in human
preeclampsia might be suggested. However, the oppo-
site–the reduction of Snail protein–m a yi n d i c a t et h a t
other factors associated with pregnancy and/or pree-
clampsia may have a greater effect on Snail, and thus
affect normal placental development. Indeed, compro-
mised oxygenation of placentas in preeclampsia is
thought to be secondary to the primary cause of pree-
clampsia–placental insufficiency due to defective tropho-
blast functions [3,6,52,55].
The similarity between Snail down-regulation in
human preeclampsi aa n di nt h er a tm o d e lm a yp r o v i d e
additional information about factors which may modu-
late Snail expression and stability in placentas. The last
week of normal rat pregnancy is characterized by expan-
sion of the labyrinth, cessation of spongiotrophoblast
proliferation, and TGC invasion of the uterine mesome-
trial compartment [27]. These developmental events
coincide with a significant decrease in maternal blood
pressure. Maternal insult in the form of a 20-fold
increase in dietary salt during this period of gestation
causes a dramatic elevation of blood pressure accompa-
nied by increased placental oxidative stress and inflam-
mation [25].
Throughout normal pregnancy, maternal blood pres-
sure is decreased despite dramatic increases in extracel-
lular fluid volume and salt retention due to persistent
activation of the renin-angiotensin-aldosterone system
(RAAS) and placental secretion of the endogenous car-
diotonic steroids, inhibitors of Na, K-ATPase [56,57].
RAAS, especially its utero-placental component, has
been recently implicated in the pathology of preeclamp-
sia [56]. Particularly, angiotensin II and IV have been
shown to regulate invasion, migration and apoptosis of
the rat and human trophoblasts [56,58]. These facts sug-
gest that utero-placental and circulating hormones
involved in blood pressure control during pregnancy
might play a more important role in the direct
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Page 8 of 11regulation of trophoblast differentiation than has been
appreciated.
Although no significant correlations were found
between salt consumption and preeclampsia develop-
ment, some epidemiological studies reported small yet
significant correlation between salt intake and hyper-
tension in humans [59]. Recent data demonstrated
higher salt sensitivity and pressor response to salt
loading in women with a history of hypertensive preg-
nancy when compared to normotensives [60]. Placental
and maternal changes in the salt-induced rat model of
preeclampsia mirror many of those noted in humans
[25,26,61,62]. However, unlike in humans, rats with
preeclampsia symptoms due to salt-overload demon-
strated large (~44%) decrease in food intake, significant
reduction of pregnancy-related maternal weight gain
and fewer pups [24,26]. Caloric restriction of 50% dur-
ing the second half of rat pregnancy alone can cause a
decrease of maternal and fetal weight and placental
alterations [63]. Placenta, and labyrinth specifically,
from undernourished pregnant rats have significantly
increased apoptosis [64]. However, apoptosis is ele-
vated in a variety of pregnancy complications including
preeclampsia [65]. An increased rate of placental apop-
tosis was shown in the salt-induced rat model as well
[25]. Since there are no reports demonstrating caloric
restriction as a possible risk factor for preeclampsia
development, maternal undernutrition in pregnant rats
on a high sodium uptake is one of the limitations of
this model and should be considered in the design of
future studies.
Conclusions
This study demonstrates that in the human and rat pla-
centas Snail is expressed in trophoblast and mesenchy-
mal progenitor cell lineages during their transition to
the terminally differentiated stage. These observations
are congruent with previously reported Snail expression
in some of these lineages, such as rat spongiotropho-
blasts, human EVT and trophoblast cell lines. We also
found that in human preeclampsia and in the rat salt-
induced model of preeclampsia, the level of transcrip-
tion factor Snail is significantly decreased in total pla-
centa extracts. The reduced levels of Snail might trigger
alterations in diverse pathways of placental cell lineage
differentiation and thus contribute to the development
of preeclampsia and/or IUGR.
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